Skip to content

Nutrient Supplementation Influences Mitochondria Adaptation

Effect of Whey Protein Hydrolysate on Adaptions to Endurance Training in Well-trained Runners

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03561337
Enrollment
24
Registered
2018-06-19
Start date
2013-10-01
Completion date
2014-06-01
Last updated
2020-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutrition, Performance, Protein

Brief summary

Twenty-four well trained runners (VO2max 60.73.7 ml O2 Kg-1 min1) completed a six week block randomized controlled intervention period. Subjects were randomly assigned to either PRO-CHO or CHO and matched in pairs for gender, age, VO2max, training and performance status. The PRO- CHO group ingested a protein beverage (0.3g kg-1) before and protein-carbohydrate beverage (0.3g protein kg-1 and 0.1g carbohydrate kg-1) after each exercise session. The CHO group ingested energy matched carbohydrate. Post-absorptive muscle biopsies were obtained pre and post intervention for analysis HAD, CS and PGC-1. Subjects completed two physical tests 6 km performance test (pre, week 1 and week 6) and aVo2max test (pre and post intervention).

Interventions

DIETARY_SUPPLEMENTPROTEIN-CARBOHYDRATE

PRO before and PRO-CHO after training

DIETARY_SUPPLEMENTCARBOHDYRATE

CHO before and after training

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Masking description

Single blinded

Intervention model description

block randomized controlled intervention

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

1. maximal oxygen uptake (VO2max) of \>50ml O2 kg-1 min-1 for women and \>55ml O2 kg-1 min-1 for men, 2. running at least 3 times a week and 3. running being the primarily training form

Exclusion criteria

1. use of medicine 2. diagnosed metabolic diseases 3. injuries which hindered running and body mass index (BMI) \< 25 kg m-2

Design outcomes

Primary

MeasureTime frameDescription
Maximal oxygen uptakeChange from week 1 to week 6maximal oxygen uptake (L O2/min)

Secondary

MeasureTime frameDescription
PerformanceChange from week 1 to week 66 km trial test
VDACChange from week 1 to week 6Mitochondria target measured by western blotting
CytCChange from week 1 to week 6Mitochondria enzyme measured by western blotting
HSP60Change from week 1 to week 6Mitochondria target measured by western blotting
CD36Change from week 1 to week 6Fat transporter measured by western blotting
COX-IVChange from week 1 to week 6Mitochondria target measured by western blotting

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026